川金诺(300505.SZ)拟发行3.68亿元可转债 初始转股价19.15元/股
格隆汇10月13日丨川金诺(300505.SZ)公布,本次向不特定对象发行可转换公司债券已获得中国证监会证监许可[2020]2260号文注册同意。本次发行总额为人民币3.68亿元可转债,每张面值为人民币100元,共计368万张,按面值发行。可转债简称为“金诺转债”,债券代码为“123069”。初始转股价格19.15元/股。
本次可转债发行原股东优先配售日与网上申购日同为2020年10月16日(T日)。
本次拟向不特定对象发行可转换公司债券募集资金总额不超过36,800.00万元,用于湿法磷酸净化及精细磷酸盐项目及补充流动资金。
网上路演时间:2020年10月15日(星期四)15:00-17:00
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.